Literature DB >> 12987937

An interpretation of the significance of influenza virus variation for the development of an effective vaccine.

J E SALK.   

Abstract

Entities:  

Keywords:  INFLUENZA VIRUS/variability; INFLUENZA/prevention and control

Mesh：

Substances：

Year:  1952        PMID： 12987937      PMCID： PMC1877218     

Source DB:  PubMed          Journal:  Bull N Y Acad Med        ISSN： 0028-7091


× No keyword cloud information.
  10 in total

1.  A critique of serologic methods for the study of influenza viruses.

Authors:  J E SALK
Journal:  Arch Gesamte Virusforsch       Date:  1951

2.  The use of adjuvants to facilitate studies on the immunologic classification of poliomyelitis viruses.

Authors:  J E SALK; L J LEWIS; J S YOUNGNER; B L BENNETT
Journal:  Am J Hyg       Date:  1951-09

3.  Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report.

Authors:  T Francis; J E Salk; J J Quilligan
Journal:  Am J Public Health Nations Health       Date:  1947-08

4.  System for measuring and designating antigenic components of influenza viruses with analyses of recently isolated strains.

Authors:  M R HILLEMAN
Journal:  Proc Soc Exp Biol Med       Date:  1951-10

5.  Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic.

Authors:  G MEIKLEJOHN; C H KEMPE; W G THALMAN; E H LENNETTE
Journal:  Am J Hyg       Date:  1952-01

6.  The spread of influenza; evidence from 1950-1951.

Authors:  A ISAACS; C H ANDREWES
Journal:  Br Med J       Date:  1951-10-20

7.  Direction of research on vaccination against influenza; new studies with immunologic adjuvants.

Authors:  J E SALK; A M LAURENT; M L BAILEY
Journal:  Am J Public Health Nations Health       Date:  1951-06

8.  Adventures among viruses; epidemic influenza.

Authors:  C H ANDREWES
Journal:  N Engl J Med       Date:  1950-02-09       Impact factor: 91.245

9.  The use of adjuvants in studies on influenza immunization. II. Increased antibody formation in human subjects inoculated with influenza virus vaccine in a water in-oil emulsion.

Authors:  J E SALK; M L BAILEY; A M LAURENT
Journal:  Am J Hyg       Date:  1952-05

10.  The use of adjuvants in studies on influenza immunization. I. Measurements in monkeys of the dimensions of antigenicity of virus-mineral oil emulsions.

Authors:  J E SALK; A M LAURENT
Journal:  J Exp Med       Date:  1952-05-01       Impact factor: 14.307
  10 in total
  6 in total

1.  Combinations of Asian influenza virus and adenovirus vaccine in the prophylaxis of respiratory illness of Navy recruits. (Part I).

Authors:  I SCHULTZ; W T STILLE; B F GUNDELFINGER; L F MILLER
Journal:  Am J Public Health Nations Health       Date:  1960-04

2.  On the antigenic variation of the influenza A virus.

Authors:  G TAKATSY; J FURESZ
Journal:  Arch Gesamte Virusforsch       Date:  1957

Review 3.  Evaluating the case for trivalent or quadrivalent influenza vaccines.

Authors:  David Baxter
Journal:  Hum Vaccin Immunother       Date:  2016-07-19       Impact factor: 3.452

4.  Antigenic memory to influenza A viruses in man determined by monovalent vaccines.

Authors:  W M Marine; J E Thomas
Journal:  Postgrad Med J       Date:  1979-02       Impact factor: 2.401

5.  The influenza virus: its morphology, immunology, and kinetics of multiplication.

Authors:  P von MAGNUS
Journal:  Bull World Health Organ       Date:  1953       Impact factor: 9.408

6.  Antigenic variants of influenza A virus, PR8 strain. I. Their development during serial passage in the lungs of partially immune mice.

Authors:  P GERBER; C G LOOSLI; D HAMBRE
Journal:  J Exp Med       Date:  1955-06-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.